Indian generic drugmaker to launch Leo Pharma copycat drug in US
Generic drugmaker Glenmark has received 180-day generic drug exclusivity on one of Leo Pharma’s inventions.
by christian bundgaard, translated by daniel pedersen
Glenmark, an Indian maker of generic drugs, has won final approval for a copy version of Leo Pharma’s Enstilar (betamethason+calcipotriol) in the US, the company announces in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Indian generic drugmaker settles lawsuit with Leo Pharma
For subscribers
